Answers are grounded in this paper and cite their sources.
ANAM is a potent and highly specific ghrelin receptor agonist with significant appetite-enhancing activity, leading to increases in FI and BW, and a stimulatory effect on GH secretion. These results support the continued investigation of ANAM as a potential treatment of cancer anorexia-cachexia syndrome.
No takes yet. Share an insight, caveat, or question.
Pietra et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: